These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8873528)

  • 1. CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer.
    Willett CG; Daly WJ; Warshaw AL
    Am J Surg; 1996 Oct; 172(4):350-2. PubMed ID: 8873528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of serum CA 19-9 monitoring in preoperative radiotherapy for pancreatic cancer.
    Ohara K; Tatsuzaki H; Molotkova NG; Oda T; Yuzawa K; Saida Y; Matsuzaki Y; Shimizu W; Todoroki T; Fukao K; Tanaka N; Itai Y
    Hepatogastroenterology; 2001; 48(39):859-63. PubMed ID: 11462942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer.
    Ishii H; Okada S; Sato T; Wakasugi H; Saisho H; Furuse J; Ishikawa O; Matsuno S; Yokoyama S
    Hepatogastroenterology; 1997; 44(13):279-83. PubMed ID: 9058159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
    Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
    J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer.
    Okusaka T; Okada S; Sato T; Wakasugi H; Saisho H; Furuse J; Ishikawa O; Matsuno S; Yokoyama S
    Hepatogastroenterology; 1998; 45(21):867-72. PubMed ID: 9684148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
    Kondo N; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Shigemoto N; Kato Y; Ohge H; Sueda T
    Ann Surg Oncol; 2010 Sep; 17(9):2321-9. PubMed ID: 20336387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
    Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
    Kobayashi N; Fujita K; Fujisawa T; Takahashi H; Yoneda M; Abe Y; Inamori M; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):65-70. PubMed ID: 18195530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic value of CA 19-9 in the preoperative work-up of pancreatic cancer patients].
    Grinbaum R; Nissan A; Beglaibter N; Cohen T; Peretz T; Freund HR
    Harefuah; 2006 Nov; 145(11):793-4, 863. PubMed ID: 17183947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant therapy for pancreatic cancer: the Duke experience.
    White RR; Tyler DS
    Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
    Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
    Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis.
    Valentini V; Morganti AG; Macchia G; Mantini G; Mattiucci GC; Brizi MG; Alfieri S; Bossola M; Pacelli F; Sofo L; Doglietto G; Cellini N
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1094-9. PubMed ID: 18313525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer.
    Shibamoto Y; Nishimura U; Abe M
    Hepatogastroenterology; 1996; 43(8):326-32. PubMed ID: 8714224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.